ACC Rockies Chapter Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit: ACC Rockies Chapter Meeting 2025

Alina Robert, MD, FACC Chapter President

Robert Duerr, MD, FACC Incoming Governor

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • Essence-CTA: Does Olezarsen Reduce Noncalcified Coronary Plaque Volume?
    In patients with moderate hypertriglyceridemia, significant reductions in triglyceride and remnant cholesterol levels with olezarsen, on top of standard-of-care lipid-lowering therapy, did not translate into a significant change from baseline in noncalcified coronary plaque volume (NCPV), according to results from Essence-CTA, a substudy of the Essence-TIMI 73b trial, presented during a Late-Breaking Clinical Trial session […]
  • SMART-DECISION: Discontinuing Beta-Blockers Safe 1 Year Post MI For Stable Patients
    Discontinuing beta-blocker therapy was found to be noninferior to continuing the therapy among stable, low-risk patients who took it for at least one year following a myocardial infarction (MI), according to the SMART-DECISION trial presented during a Late-Breaking Clinical Trial session during ACC.26 in New Orleans and simultaneously published in NEJM.
  • Dig-RHD: Digoxin Reduces Mortality, HF in Patients With RHD
    Digoxin lowered the risk of death or new-onset or worsening heart failure (HF) compared with placebo in patients with rheumatic heart disease (RHD), according to results from the Dig-RHD trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans.
  • THRIVE: Culturally Tailored Food-is-Medicine Program Lowers BP in Black and Hispanic Adults
    A culturally tailored food-is-medicine intervention significantly reduced systolic blood pressure (SBP) in Black and Hispanic adults with hypertension, compared with those who received an equivalent amount of fresh produce without the additional supports, according to results from the THRIVE trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans.
  • Early Action, Better Outcomes: Prevention Drives the Future of Heart Health
    Heart disease remains the leading cause of death worldwide, yet a substantial proportion of cases are preventable with timely, evidence-based intervention – particularly when risk identification and prevention efforts begin early in life, including in childhood. With this in mind, the ACC is reinforcing its commitment to equipping clinicians with the actionable knowledge needed to […]